Agonists of 5-HT1A receptors are divided into partial (partial) and full agonists .
Content
List of 5-HT1A receptor agonists
Complete 5-HT1A receptor agonists
- 8-OH-DPAT [1]
- Alnespiron [2] [3] [4]
- Befiradol . [5] [6] [7] [8] [9] [10]
- Eptapiron [11] [12]
- F-15,599 [13] [14]
- Lesopitron [15]
- LY-293,284 [16] [17]
- Osemozotan [18]
- Repinotan [19] [20]
- U-92,016-A [21] [22]
Partial agonists of 5-HT1A receptors
Partial agonists are agonists that show less ability to stimulate the receptor than full agonists.
Partial agonists of the 5-HT1A serotonin receptor are many substances and drugs , including a number of antidepressants , non-benzodiazepine anxiolytics , typical and atypical antipsychotics , as well as some hallucinogens and empathogens , some anti-migraine , anti-parkinsonian , hypotensive drugs.
Antidepressants
- Trazodon
- Nefazodon
- Vilazodon
- Vortioxetine
Nonbenzodiazepine anxiolytics
- Binospiron
- Buspirone
- Gepiron
- Zalospiron
- Cannabidiol
- Ipsapiron
- Perospiron
- Tandospiron
- Thiospiron
Atypical antipsychotics
- Aripiprazole
- Asenapine
- Ziprasidone
- Quetiapine
- Clozapine
- Lurazidone
- Olanzapine
Typical Antipsychotics
- Haloperidol
Antihypertensives
- Urapidil
- Rauwolscin
Anti-migraine drugs
- Ergotamine
- Dihydroergotamine
Hallucinogens
- LSD
- Psilocin
- Psilocybin
Empathogens
- MDMA
Dopaminergic anti-Parkinsonian drugs
- Lizurid
Libido and Sexual Drugs
- Yohimbine
Miscellaneous and research preparations
- 5-carboxamidotryptamine (5-CT)
- 5-methoxytryptamine (5-MT)
- 5-MeO-DMT
- Adatanserin
- Flibanserin
- Alpha ethyltryptamine (αET)
- Alpha Methyltryptamine (αMT)
- Bay r 1531
- Befiradol
- Bufotenin
- Eltoprazine
- Etoperidone
- F-11,461
- F-12.826
- F-13,714
- F-14.679
- Flesinoxane
- Ginkgo Biloba [23]
- LY-301,317
- Ebalzotan
- Naluzotan
- Piclozotan
- Sarisotan
- NBUMP
- RU-24,969
- S-15,535
- SSR-181,507
- Sunepitron
- Trifluoromethylphenylpiperazine
- Xaliproden
Notes
- ↑ Winsauer PJ, Rodriguez FH, Cha AE, Moerschbaecher JM Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats // J. Pharmacol. Exp. Ther. : journal. - 1999 .-- January ( vol. 288 , no. 1 ). - P. 335—347 . - PMID 9862788 .
- ↑ Griebel G., Misslin R., Pawlowski M., Guardiola Lemaître B., Guillaumet G., Bizot-Espiard J. Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice. (English) // Neuroreport. : journal. - 1992. - Vol. 3 , no. 1 . - P. 84-86 . - DOI : 10.1097 / 00001756-199201000-00022 . - PMID 1351756 .
- ↑ Simon P., Guardiola B., Bizot-Espiard J., Schiavi P., Costentin J. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists. (Eng.) // Psychopharmacology : journal. - Springer , 1992. - Vol. 108 , no. 1-2 . - P. 47-50 . - DOI : 10.1007 / BF02245284 . - PMID 1357709 .
- ↑ Astier B., Lambás Señas L., Soulière F., Schmitt P., Urbain N., Rentero N., Bert L., Denoroy L., Renaud B., Lesourd M., Muñoz C., Chouvet G. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity. (English) // Eur J Pharmacol. : journal. - 2003. - Vol. 459 , no. 1 . - P. 17-26 . - DOI : 10.1016 / S0014-2999 (02) 02814-5 . - PMID 12505530 .
- ↑ Bardin L., Tarayre JP, Malfetes N., Koek W., Colpaert FC Profound, non-opioid analgesia produced by the high-efficacy 5-HT (1A) agonist F 13640 in the formalin model of tonic nociceptive pain ) // Pharmacology: journal. - 2003 .-- April ( vol. 67 , no. 4 ). - P. 182-194 . - DOI : 10.1159 / 000068404 . - PMID 12595749 .
- ↑ Bruins Slot LA, Koek W., Tarayre JP, Colpaert FC Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640 (English) // European Journal of Pharmacology : journal. - 2003 .-- April ( vol. 466 , no. 3 ). - P. 271—279 . - DOI : 10.1016 / S0014-2999 (03) 01566-8 . - PMID 12694810 .
- ↑ Bardin L., Assié MB, Pélissou M., Royer-Urios I., Newman-Tancredi A., Ribet JP, Sautel F., Koek W., Colpaert FC Dual, hyperalgesic, and analgesic effects of the high-efficacy 5 -hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl) - [4-fluoro-4 - {[(5-methyl-pyridin-2-ylmethyl) -amino] -methyl} piperidin-1-yl] methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters (Eng.) // The Journal of Pharmacology and Experimental Therapeutics : journal. - 2005 .-- March ( vol. 312 , no. 3 ). - P. 1034-1042 . - DOI : 10.1124 / jpet.104.077669 . - PMID 15528450 .
- ↑ Colpaert FC, Deseure K., Stinus L., Adriaensen H. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning (Eng.) // The Journal of Pharmacology and Experimental Therapeutics : journal. - 2006 .-- February ( vol. 316 , no. 2 ). - P. 892-899 . - DOI : 10.1124 / jpet.105.095109 . - PMID 16254131 .
- ↑ Deseure K., Bréand S., Colpaert FC Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT (1A) receptor agonist (eng.) // European Journal of Pharmacology : journal. - 2007 .-- July ( vol. 568 , no. 1-3 ). - P. 134-141 . - DOI : 10.1016 / j.ejphar.2007.04.0.022 . - PMID 17512927 .
- ↑ Bernard Vacher, Bernard Bonnaud, Wouter Koek. Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine. US Patent 6020345, May 21, 1999.
- ↑ Koek W., Patoiseau JF, Assié MB, et al. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential (English) // The Journal of Pharmacology and Experimental Therapeutics : journal. - 1998 .-- October ( vol. 287 , no. 1 ). - P. 266-283 . - PMID 9765347 .
- ↑ Prinssen EP, Colpaert FC, Koek W. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy (English) // European Journal of Pharmacology : journal. - 2002. - October ( vol. 453 , no. 2-3 ). - P. 217-221 . - DOI : 10.1016 / S0014-2999 (02) 02430-5 . - PMID 12398907 .
- ↑ Maurel JL, Autin JM, Funes P., Newman-Tancredi A., Colpaert F., Vacher B. High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity ( Journal ) // Journal of Medicinal Chemistry : journal. - 2007 .-- October ( vol. 50 , no. 20 ). - P. 5024-5033 . - DOI : 10.1021 / jm070714l . - PMID 17803293 .
- ↑ Newman-Tancredi A., Martel JC, Assié MB, et al. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist (Eng.) // British Journal of Pharmacology : journal. - 2009 .-- January ( vol. 156 , no. 2 ). - P. 338-353 . - DOI : 10.1111 / j.1476-5381.2008.00001.x . - PMID 19154445 .
- ↑ Haj-Dahmane S., Jolas T., Laporte AM, et al. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat // English Journal of Pharmacology : journal. - 1994 .-- April ( vol. 255 , no. 1-3 ). - P. 185-196 . - DOI : 10.1016 / 0014-2999 (94) 90097-3 . - PMID 8026543 .
- ↑ Monte AP, Marona-Lewicka D., Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity (Eng.) // Journal of Medicinal Chemistry : journal. - 1998 .-- June ( vol. 41 , no. 12 ). - P. 2134-2145 . - DOI : 10.1021 / jm980076u . - PMID 9622555 .
- ↑ Foreman MM, Fuller RW, Rasmussen K., Nelson DL, Calligaro DO, Zhang L., Barrett JE, Booher RN, Paget CJ, Flaugh ME Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity .) // The Journal of Pharmacology and Experimental Therapeutics : journal. - 1994 .-- September ( vol. 270 , no. 3 ). - P. 1270-1281 . - PMID 7523657 .
- ↑ Matsuda T. , Yoshikawa T. , Suzuki M. , Asano S. , Somboonthum P. , Takuma K. , Nakano Y. , Morita T. , Nakasu Y. , Kim HS Novel benzodioxan derivative, 5- (3 - [( (2S) -1,4-benzodioxan-2-ylmethyl) amino propoxy) -1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.] / / Japanese journal of pharmacology. - 1995. - Vol. 69, no. 4 . - P. 357-366. - PMID 8786639 .
- ↑ De Vry J. , Schohe-Loop R. , Heine HG , Greuel JM , Mauler F. , Schmidt B. , Sommermeyer H. , Glaser T. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist . (Eng.) // The Journal of pharmacology and experimental therapeutics. - 1998. - Vol. 284, no. 3 . - P. 1082-1094. - PMID 9495870 .
- ↑ Dong J. , de Montigny C. , Blier P. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe. (Eng.) // The Journal of pharmacology and experimental therapeutics. - 1998. - Vol. 286, no. 3 . - P. 1239-1247. - PMID 9732384 .
- ↑ Romero AG, Leiby JA, McCall RB, Piercey MF, Smith MW, Han F. Novel 2-substituted tetrahydro-3H-benz [e] indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants . (Eng.) // J Med Chem. : journal. - 1993. - Vol. 36 , no. 15 . - P. 2066-2074 . - DOI : 10.1021 / jm00067a003 . - PMID 8101876 .
- ↑ McCall RB, Romero AG, Bienkowski MJ, Harris DW, McGuire JC, Piercey MF, Shuck ME, Smith MW, Svensson KA, Schreur PJ, et al. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. (English) // J Pharmacol Exp Ther. : journal. - 1994. - Vol. 271 , no. 2 . - P. 875-883 . - PMID 7965808 .
- ↑ Winter JC, Timineri D. The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba (Eng.) // Pharmacol. Biochem. Behav. : journal. - 1999 .-- March ( vol. 62 , no. 3 ). - P. 543-547 . - DOI : 10.1016 / S0091-3057 (98) 00190-7 . - PMID 10080249 .